Skip to main content

How to switch from Abilify Maintena to Aristada?

Medically reviewed by Philip Thornton, DipPharm. Last updated on Nov 15, 2024.

Official answer

by Drugs.com

Abilify Maintena (aripiprazole) and Aristada (aripiprazole lauroxil) contain an atypical antipsychotic. They are both used to treat adults with schizophrenia.

Aristada contains aripiprazole lauroxil - a prodrug of aripiprazole - which is the active ingredient in Abilify Maintena. When patients take Aristada, aripiprazole lauroxil is converted to aripiprazole by the body.

Abilify Maintena and Aristada are extended release (depot) injections that are administered by a healthcare professional into the patient’s deltoid or gluteal muscle.

Switching from Abilify Maintena to Aristada

The recommended starting and maintenance dose of Abilify Maintena is 400mg a month. It takes four doses to reach steady state concentrations of the drug - for the amount of the drug being absorbed to match the amount being cleared from the body.

Patients stabilized on Abilify Maintena 400 mg a month who have reached steady state concentrations can be switched to Aristada 882 mg four weeks after their last Abilify Maintena 400 mg intramuscular injection.

Why switch from Abilify Maintena to Aristada?

Although they both contain aripiprazole, sometimes people will need to switch from Abilify Maintena to Aristada because of:

  • Insurance plan coverage
  • Needing a long acting injectable medication. Abilify Maintena is administered monthly, but Aristada can be administered monthly, every six weeks or every two months.
References
  • Food and Drug Administration (FDA). Abilify Maintena. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf. [Accessed November 26, 2020].
  • Food and Drug Administration (FDA). Aristada. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf. [Accessed November 26, 2020].
  • Raedler LA. Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia. Am Health Drug Benefits. 2016;9(Spec Feature):40-43.
  • Citrome L. Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil. Expert Rev Clin Pharmacol. 2016;9(2):169-186. doi:10.1586/17512433.2016.1121809.
  • SMI Adviser. What should I consider and how do I change or switch a patient from a different long acting injectable (LAI) antipsychotic medication to Aristada? April 22, 2020. Available from: https://smiadviser.org/knowledge_post/what-should-i-consider-and-how-do-i-change-or-switch-a-patient-from-a-different-long-acting-injectable-lai-antipsychotic-medication-to-aristada. [Accessed November 26, 2020].

Read next

What is the difference between Abilify and Abilify Maintena?

The main differences between Abilify and Abilify Maintena are how they are supplied, how they are administered, their FDA-approved uses and their costs. They both contain the active ingredient aripiprazole, an atypical antipsychotic, and are approved for the treatment of schizophrenia and bipolar disorder. Continue reading

How do you administer Abilify Maintena?

You do not administer Abilify Maintena to yourself. Abilify Maintena is an injection given only by a healthcare provider at a doctor’s office or hospital once every month. It is injected into the deltoid (upper arm) muscle or gluteal (buttock) muscle. Continue reading

How often is Abilify Maintena given?

Abilify Maintena is injected into a muscle into your upper arm or buttock once a month. It is an extended-release medicine used to treat schizophrenia and bipolar I disorder in adults. It is only given by a healthcare provider in a doctor’s office or hospital. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer